In a comparison of two commercially available chlamydial isolation systems in which cycloheximide-treated McCoy cell monolayers are used, the system from Bartels Immunodiagnostic Supplies, Inc., Bellevue, Wash., was found to be superior to that from M. A. Bioproducts Recent advances in chlamydial isolation procedures have made it technically feasible for clinical microbiology laboratories to offer isolation of Chlamydia trachomatis as a routine diagnostic procedure (15, 19) . In addition, several commercial companies currently market materials for the isolation of C. trachomatis as complete systems. These systems use cycloheximide-treated McCoy cell monolayers, a method which has been shown in a number of studies to be optimal for C. trachomatis isolation (3, 6, 10, 12, 16 Cell cultures. McCoy cell monolayers on cover slips in 1-dram shell vials overlaid with maintenance medium were obtained on a weekly basis from Bartels Immunodiagnostic Supplies, Inc., Bellevue, Wash., and MAB. The monolayers were held at room temperature for up to 1 week before use. Immediately before inoculation, the maintenance medium was removed aseptically.
Recent advances in chlamydial isolation procedures have made it technically feasible for clinical microbiology laboratories to offer isolation of Chlamydia trachomatis as a routine diagnostic procedure (15, 19) . In addition, several commercial companies currently market materials for the isolation of C. trachomatis as complete systems. These systems use cycloheximide-treated McCoy cell monolayers, a method which has been shown in a number of studies to be optimal for C. trachomatis isolation (3, 6, 10, 12, 16) . However, because it has been previously shown that McCoy cell lines from different sources may differ in their abilities to support chlamydial growth (19) , this study was initiated to evaluate the performance characteristics of two of the commercially available cell culture systems for C. trachomatis detection in clinical specimens.
(A preliminary report of this work was presented previously [M. K. Robison [3, 10, 16] , high counts were defined in this study as .10 inclusions per cover slip and low counts as <10 inclusions per cover slip.) Conversely, most specimens positive in only one system yielded low inclusion counts (13 of 17 or 76%, 12 of which were positive in the Bartels system). However, >500 inclusions per cover slip were counted in one Bartels-positive, MAB-negative specimen. With both systems, the number of specimens uninterpretable owing to overgrowth of contaminants (primarily yeasts) was low, although greater with the MAB system (2.1%) than with the Bartels system (0.4%). In addition, some breakthrough growth of contaminants occasionally partially obscured observation of the monolayer in the MAB system. In three Bartelspositive, MAB-negative specimens, this contaminant growth may have contributed to the failure to detect inclusions.
A comparison of the inclusion counts for the 47 positive specimens also demonstrated that the Bartels system produced higher counts more frequently, with 34 (72%) counts greater in the Bartels system, 6 (13%) counts greater in the MAB system, and 7 (15%) counts being equivalent (P < 0.001 by the matched-pair sign test) in both systems. The Bartels monolayers generally yielded 2-to 10-fold-greater counts. Included in the group with greater counts in the MAB system were four low-titer specimens and both positive nasopharyngeal specimens. In the group showing equivalent counts, five were high-titer specimens with inclusions too numerous to count, and two had a single inclusion detected in each system.
Recovery from passaged clinical isolates. A comparison of the inclusion counts produced in the two systems, using inocula prepared from passaged clinical isolates, supported previous findings with clinical specimens that the Bartels system yielded higher counts (Table 2 ). In experiments in which three different pools of passaged endocervical isolates and different weekly cell shipments were used, significantly greater ent time periods in which one system was used exclusively is shown in Table 3 . A significantly greater isolation rate was seen when the Bartels system was used (P < 0.001 by standardized normal deviate analysis for unpaired data). In addition, the number of specimens which were uninterpretable owing to overgrowth of genital microflora was significantly lower in the Bartels system (P < 0.001). Although one cannot exclude the possibility that factors other than isolation system used contributed to these differences, the results nevertheless parallel the findings in the matched-pair studies.
DISCUSSION
Previous studies have demonstrated that differences in detection of C. trachomatis in cycloheximide-treated McCoy cells by iodine staining related to differences in system components. Smith et al. (19) noted that McCoy cell lines from different sources differed in their abilities to support chlamydial growth from clinical specimens and stock cultures, with a University of Washington line superior to the MAB or Flow lines. They suggested that these differences might be related to specific differences in cell culture handling procedures which could affect chlamydial susceptibility. It is of note that the Bartels system uses a University of Washingtonderived line which has been selected on the basis of optimal recovery of chlamydia (P. Bartels, personal communication). The results of this study similarly indicate that the cell cultures in the two commercial systems evaluated may not be equivalent for the recovery of C. trachomatis.
Differences in the composition of the overlay media in the two systems may also have contributed to the differences observed in chlamydial recovery. Serum source is known to influence chlamydial development (1, 11) , and some lots of fetal calf serum have been found to have a profoundly suppressive effect on isolation in cycloheximide-treated McCoy cell monolayers (5) . The difference in cycloheximide concentration (1.0 ,ug/ml in Bartels; 0.5 ,ug/ml in MAB) may have also been a contributing factor (16) .
Although the contamination rates were low with both systems compared with previously reported values, particularly for cervical specimens (15) , the data here indicate that the Bartels system better suppressed overgrowth by other microorganisms. This difference is probably related to differences in the antimicrobic composition of the overlay media in the two systems.
Of the specimens detected in only one system, 76% were low-yield specimens (<10 average inclusions per cover slip), and a similar percentage of specimens detected in both systems were high-yield specimens (>10 inclusions per cover slip). This finding is consistent with previous observations in comparisons of isolation methods that 'high-yield specimens will generally be detected by any method used and that critical differences in recovery should be particularly noted in low-yield specimens (3, 10, 16) . We have found that 40 to 50% of positive clinical specimens which originate from routine endocervical screening of obstetric patients are lowyield specimens. In view of the reported maternal and neonatal morbidity associated with C. trachomatis infection (7-9, 13, 14, 17, 18, 20, 21) , it is particularly important in this population to use procedures for optimal detection of all positive specimens. This study did, in fact, demonstrate a significant increase in isolation rate from an obstetric population upon changing from the MAB to the Bartels system. Although both systems were technically similar, the Bartels system was found in a comparative evaluation of two commercially available C. trachomatis isolation systems to be superior to the MAB system in terms of increased number of positive specimens detected, increased number of inclusions detected per sample, and decreased number of specimens noninterpretable owing to overgrowth with other microorganisms. These findings are probably related to specific differences in the system components 
